Literature DB >> 8291565

Age of onset in familial early onset Alzheimer's disease correlates with genetic aetiology.

M Mullan1, H Houlden, F Crawford, A Kennedy, P Rogues, M Rossor.   

Abstract

Age of onset is the most robust clinical feature demarcating aetiologic subtypes of familial Alzheimer's disease. It has previously been noted that early onset disease (arbitrarily below the age of 65 years) conforms to an autosomal dominant pattern of transmission. Late onset disease is generally thought to have a more complex aetiology. We present data here suggesting that early onset disease can be subdivided by genetic aetiology with which age of onset correlates. In general, those pedigrees showing linkage to the chromosome 14 locus have a mean age of onset in the forties whereas those pedigrees with an APP mutation have an age of onset in the fifties.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8291565     DOI: 10.1002/ajmg.1320480303

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  No founder effect in three novel Alzheimer's disease families with APP 717 Val-->Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study Group.

Authors:  D Campion; A Brice; D Hannequin; F Charbonnier; B Dubois; C Martin; A Michon; C Penet; M Bellis; A Calenda; M Martinez; Y Agid; F Clerget-Darpoux; T Frebourg
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

2.  Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset.

Authors:  Pratishtha Chatterjee; Veer B Gupta; Anne M Fagan; Mateusz S Jasielec; Chengjie Xiong; Hamid R Sohrabi; Satvinder Dhaliwal; Kevin Taddei; Pierrick Bourgeat; Belinda M Brown; Tammie Benzinger; Randall J Bateman; John C Morris; Ralph N Martins
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

Review 3.  The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin.

Authors:  Douglas G Peters; James R Connor; Mark D Meadowcroft
Journal:  Neurobiol Dis       Date:  2015-08-22       Impact factor: 5.996

Review 4.  The molecular genetics of Alzheimer's disease.

Authors:  M Mullan; F Crawford
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

Review 5.  Genetic dissection of Alzheimer disease, a heterogeneous disorder.

Authors:  G D Schellenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

Review 6.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

7.  A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease.

Authors:  Joshua D Grill; Randall J Bateman; Virginia Buckles; Angela Oliver; John C Morris; Colin L Masters; William E Klunk; John M Ringman
Journal:  Alzheimers Res Ther       Date:  2015-07-22       Impact factor: 6.982

8.  Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.

Authors:  Philip S J Weston; Jennifer M Nicholas; Manja Lehmann; Natalie S Ryan; Yuying Liang; Kirsty Macpherson; Marc Modat; Martin N Rossor; Jonathan M Schott; Sebastien Ourselin; Nick C Fox
Journal:  Neurology       Date:  2016-10-12       Impact factor: 9.910

Review 9.  Dominantly Inherited Alzheimer Network: facilitating research and clinical trials.

Authors:  Krista L Moulder; B Joy Snider; Susan L Mills; Virginia D Buckles; Anna M Santacruz; Randall J Bateman; John C Morris
Journal:  Alzheimers Res Ther       Date:  2013-10-17       Impact factor: 6.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.